BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16707584)

  • 1. State of HIV treatment: Results of the International Association of Physicians in AIDS Care surveys of HIV-positive patients and HIV-treating physicians in the United States.
    Zuniga JM
    J Int Assoc Physicians AIDS Care (Chic); 2006 Jun; 5(2):51-6. PubMed ID: 16707584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perceptions of health, HIV disease, and HIV treatment by patients in 6 regions: analysis of the 2555-person AIDS treatment for life international survey.
    Mascolini M; Zuniga JM
    J Int Assoc Physicians AIDS Care (Chic); 2008; 7(4):160-77. PubMed ID: 18626118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Switching antiretroviral therapy: why, when and how.
    Wilkin T; Glesby M; Gulick RM
    IAPAC Mon; 2006 Jul; 12(7):220-9. PubMed ID: 17096494
    [No Abstract]   [Full Text] [Related]  

  • 4. The decision to forgo antiretroviral therapy in people living with HIV compliance as paternalism or partnership?
    Kremer H; Bader A; O'Cleirigh C; Bierhoff HW; Brockmeyer NH
    Eur J Med Res; 2004 Feb; 9(2):61-70. PubMed ID: 15090291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2006 IAPAC state of HIV treatment surveys. Comprehensive insights into the mindsets of HIV-positive patients and HIV-treating physicians.
    IAPAC Mon; 2006 May; 12(5):150-5. PubMed ID: 17249141
    [No Abstract]   [Full Text] [Related]  

  • 6. Primary care and specialty care in the age of HAART.
    Soloway B
    AIDS Clin Care; 1997 May; 9(5):37-9. PubMed ID: 11364297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors and consequences of negative physician attitudes toward HIV-infected injection drug users.
    Ding L; Landon BE; Wilson IB; Wong MD; Shapiro MF; Cleary PD
    Arch Intern Med; 2005 Mar; 165(6):618-23. PubMed ID: 15795336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of hepatitis C virus and human immunodeficiency virus coinfection: from large trials to real life.
    Cacoub P; Rosenthal E; Halfon P; Sene D; Perronne C; Pol S
    J Viral Hepat; 2006 Oct; 13(10):678-82. PubMed ID: 16970599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience and choice of drug therapy for human immunodeficiency virus disease.
    Brosgart CL; Mitchell TF; Coleman RL; Dyner T; Stephenson KE; Abrams DI
    Clin Infect Dis; 1999 Jan; 28(1):14-22. PubMed ID: 10028063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to clinical guidelines for the therapeutic management of HIV disease.
    Heath KV; Hogg RS; Singer J; Schechter MT; O'Shaughnessy MV; Montaner JS
    Clin Invest Med; 1997 Dec; 20(6):381-7. PubMed ID: 9413635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mother-to-child HIV transmission prevention in Thailand: physician zidovudine use and willingness to provide care.
    Bhatta MP; Stringer JS; Phanuphak P; Vermund SH
    Int J STD AIDS; 2003 Jun; 14(6):404-10. PubMed ID: 12816669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. After the euphoria: HIV medical technologies from the perspective of their prescribers.
    Rosengarten M; Imrie J; Flowers P; Davis MD; Hart GJ
    Sociol Health Illn; 2004 Jul; 26(5):575-96. PubMed ID: 15283778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Who's talking? Communication between health providers and HIV-infected adults related to herbal medicine for AIDS treatment in western Uganda.
    Langlois-Klassen D; Kipp W; Rubaale T
    Soc Sci Med; 2008 Jul; 67(1):165-76. PubMed ID: 18406030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV treatment series. Part 4 of 4. Decisions, decisions--starting or switching anti-HIV therapy.
    McGuire S
    Posit Aware; 2003; 14(3):31-6. PubMed ID: 12866490
    [No Abstract]   [Full Text] [Related]  

  • 15. Heterogeneity of physician agreement with recommended therapeutic guidelines for the management of HIV-associated disease.
    Montaner JS; Hogg RS; Heath KV; Phillips P; Craib KJ; Schechter MT; O'Shaughnessy MV
    Antivir Ther; 1996 Aug; 1(3):157-66. PubMed ID: 11322249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Taking responsibility for our own health].
    McCabe L
    Sidahora; 1997; ():20-2. PubMed ID: 11364825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of genotypic resistance testing on selection of salvage regimen in clinical practice.
    Haupts S; Ledergerber B; Böni J; Schüpbach J; Kronenberg A; Opravil M; Flepp M; Speck RF; Grube C; Rentsch K; Weber R; Günthard HF;
    Antivir Ther; 2003 Oct; 8(5):443-54. PubMed ID: 14640392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The house is burning: an HIV clinician's view after 20 years.
    Follansbee S
    Focus; 2001 Aug; 16(9):1-5. PubMed ID: 11692445
    [No Abstract]   [Full Text] [Related]  

  • 19. Antiretroviral therapies from the patient's perspective.
    Meystre-Agustoni G; Dubois-Arber F; Cochand P; Telenti A
    AIDS Care; 2000 Dec; 12(6):717-21. PubMed ID: 11177450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A kinder, gentler approach to treatment. Interview by Paul Simmons.
    Mauss S
    Res Initiat Treat Action; 1998 Aug; 4(5):3-5. PubMed ID: 11365708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.